RepliCel Announces a Binding Term Sheet For Strategic Investment and U.S. Partnership
Transactionrepresents RepliCel’s entrance into the U.S. market Investment termsminimize dilution and puts RepliCel on-track for US FDA marketing approvalsofthe RepliCel Dermal InjectorProduct Line ...